Paritaprevir/ritonavir, ombitasvir, and dasabuvir for treatment of recurrent hepatitis C virus infection in the human immunodeficiency virus coinfected liver transplant recipient-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Paritaprevir/ritonavir, ombitasvir, and dasabuvir for treatment of recurrent hepatitis C virus infection in the human immunodeficiency virus coinfected liver transplant recipient

Published:2016-01-27 Issue:2 Volume:22 Page:252-253
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Sollima Salvatore¹,Milazzo Laura¹,Torre Alessandro¹,Calvi Elisa¹,Regalia Enrico²,Antinori Spinello¹

Affiliation:

1. III Division of Infectious Diseases; L. Sacco University Hospital; Milan Italy

2. Liver Unit, Department of Surgery, National Cancer Institute; IRCCS Foundation; Naples Italy

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Reference6 articles.

1. Reply;Gutierrez;Liver Transpl,2015

2. Liver transplantation in HIV patients;Fox;Semin Liver Dis,2012

3. Outcome and management of HCV/HIV coinfection pre- and post-liver transplantation. A 2015 update;Miro;J Hepatol,2015

4. Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial;Sulkowski;JAMA,2015

5. An interferon-free antiviral regimen for HCV after liver transplantation;Kwo;N Engl J Med,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP